Seelos Therapeutics to Participate in the 33rd Annual Roth Conference
Seelos Therapeutics, Inc. a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, today announced that it will participate in the 33 rd Annual Roth Conference which will be held virtually on March 15-17, 2021 . Raj Mehra, Ph.D., Chairman and CEO, will host 1×1 meetings via conference calls on March 16 th and 17 th . About Seelos …
Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, today announced that it will participate in the 33 rd Annual Roth Conference which will be held virtually on March 15-17, 2021 .